Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Three-dimensional Digital Breast Tomosynthesis Versus Digital Mammography: Which Get the Supremacy in Diagnosis of Benign Breast Lesions in Asymptomatic Females

NCT07145892 is registered in ClinicalTrials.gov with The General Authority for Teaching Hospitals and Institutes as lead sponsor.

NCT NCT07145892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07145892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Three-dimensional Digital Breast Tomosynthesis Versus Digital Mammography: Which Get the Supremacy in Diagnosis of Benign Breast Lesions in Asymptomatic Females
Lead sponsor
The General Authority for Teaching Hospitals and Institutes
Phase
Observational
Overall status
Completed
Start date
June 1, 2024
Completion date
May 29, 2025
Enrollment
255 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic females, benign breast lesions, diagnosis, digital mammography, digital tomosynthesis, three dimension